{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,13]],"date-time":"2026-04-13T14:41:27Z","timestamp":1776091287612,"version":"3.50.1"},"reference-count":60,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.es","elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Medicina Cl\u00ednica"],"published-print":{"date-parts":[[2023,4]]},"DOI":"10.1016\/j.medcli.2023.01.003","type":"journal-article","created":{"date-parts":[[2023,2,9]],"date-time":"2023-02-09T11:13:53Z","timestamp":1675941233000},"page":"310-317","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"title":["Granulomatosis eosinof\u00edlica con poliange\u00edtis"],"prefix":"10.1016","volume":"160","author":[{"given":"Carlos","family":"Romero G\u00f3mez","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Halbert","family":"Hern\u00e1ndez Negr\u00edn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mar\u00eda del Mar","family":"Ayala Guti\u00e9rrez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.medcli.2023.01.003_bib0305","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/art.37715","article-title":"2012 revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides","volume":"65","author":"Jennette","year":"2013","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.medcli.2023.01.003_bib0310","first-page":"277","article-title":"Allergic granulomatosis, allergic angiitis, and periarteritis nodosa","volume":"27","author":"Churg","year":"1951","journal-title":"Am J Pathol."},{"key":"10.1016\/j.medcli.2023.01.003_bib0315","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1097\/00005792-198403000-00001","article-title":"Systemic vasculitis with asthma and eosinophilia: a clinical approach to the Churg-Strauss syndrome","volume":"63","author":"Lanham","year":"1984","journal-title":"Medicine (Baltimore)."},{"key":"10.1016\/j.medcli.2023.01.003_bib0320","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1055\/s-0038-1669454","article-title":"Eosinophilic Granulomatosis with Polyangiitis (Churg-Strauss)","volume":"39","author":"Nguyen","year":"2018","journal-title":"Semin Respir Crit Care Med."},{"key":"10.1016\/j.medcli.2023.01.003_bib0325","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1002\/acr.24634","article-title":"2021 American College of Rheumatology\/Vasculitis Foundation Guideline for the Management of Antineutrophil Cytoplasmic Antibody-Associated Vasculitis","volume":"73","author":"Chung","year":"2021","journal-title":"Arthritis Care Res (Hoboken)."},{"key":"10.1016\/j.medcli.2023.01.003_bib0330","doi-asserted-by":"crossref","first-page":"4829","DOI":"10.1007\/s10067-021-05783-8","article-title":"Burden of illness associated with eosinophilic granulomatosis with polyangiitis: a systematic literature review and meta-analysis","volume":"40","author":"Jakes","year":"2021","journal-title":"Clin Rheumatol."},{"key":"10.1016\/j.medcli.2023.01.003_bib0335","first-page":"S","article-title":"Epidemiological study of primary systemic vasculitides among adults in southern Spain and review of the main epidemiological studies","volume":"33","author":"Romero-Gomez","year":"2015","journal-title":"Clin Exp Rheumatol."},{"key":"10.1016\/j.medcli.2023.01.003_bib0340","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1038\/s41584-021-00718-8","article-title":"Global epidemiology of vasculitis","volume":"18","author":"Watts","year":"2022","journal-title":"Nat Rev Rheumatol."},{"key":"10.1016\/j.medcli.2023.01.003_bib0345","doi-asserted-by":"crossref","first-page":"93","DOI":"10.5578\/tt.20229911","article-title":"Eosinophilic granulomatosis with polyangitis: A new target for biologicals","volume":"70","author":"Bayrak Durmaz","year":"2022","journal-title":"Tuberk Toraks."},{"key":"10.1016\/j.medcli.2023.01.003_bib0350","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41467-019-12515-9","article-title":"Genome-wide association study of eosinophilic granulomatosis with polyangiitis reveals genomic loci stratified by ANCA status","volume":"10","author":"Lyons","year":"2019","journal-title":"Nat Commun."},{"key":"10.1016\/j.medcli.2023.01.003_bib0355","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.1016\/j.jaip.2018.07.001","article-title":"Eosinophilic Granulomatosis with Polyangiitis: Clinical Pathology Conference and Review","volume":"6","author":"Wu","year":"2018","journal-title":"J Allergy Clin Immunol Pract."},{"key":"10.1016\/j.medcli.2023.01.003_bib0360","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1378\/chest.117.3.708","article-title":"Churg- Strauss syndrome in patients receiving montelukast as treatment for asthma","volume":"117","author":"Wechsler","year":"2000","journal-title":"Chest."},{"key":"10.1016\/j.medcli.2023.01.003_bib0365","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1378\/chest.08-2990","article-title":"Churg-Strauss syndrome in patients treated with omalizumab","volume":"136","author":"Wechsler","year":"2009","journal-title":"Chest."},{"key":"10.1016\/j.medcli.2023.01.003_bib0370","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1016\/j.alit.2019.06.004","article-title":"Update on eosinophilic granulomatosis with polyangiitis","volume":"68","author":"Furuta","year":"2019","journal-title":"Allergol Int."},{"key":"10.1016\/j.medcli.2023.01.003_bib0375","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1002\/art.37721","article-title":"Eosinophilic granulomatosis with polyangiitis (Churg-Strauss): Clinical characteristics and long-term followup of the 383 patients enrolled in the French Vasculitis Study Group cohort","volume":"65","author":"Comarmond","year":"2013","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.medcli.2023.01.003_bib0380","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1002\/acr.22686","article-title":"Long-Term Followup of a Multicenter Cohort of 101 Patients with Eosinophilic Granulomatosis with Polyangiitis (Churg-Strauss)","volume":"68","author":"Durel","year":"2016","journal-title":"Arthritis Care Res."},{"key":"10.1016\/j.medcli.2023.01.003_bib0385","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1136\/annrheumdis-2012-201531","article-title":"A vasculitis centre based management strategy leads to improved outcome in eosinophilic granulomatosis and polyangiitis (Churg-Strauss EGPA): Monocentric experiences in 150 patients","volume":"72","author":"Moosig","year":"2013","journal-title":"Ann Rheum Dis."},{"key":"10.1016\/j.medcli.2023.01.003_bib0390","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.3899\/jrheum.171352","article-title":"Longterm outcomes of 188 Japanese patients with eosinophilic granulomatosis with polyangiitis","volume":"45","author":"Saku","year":"2018","journal-title":"J Rheumatol."},{"key":"10.1016\/j.medcli.2023.01.003_bib0395","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1093\/rheumatology\/40.7.763","article-title":"Churg-Strauss syndrome: outcome and long-term follow-up of 32 patients","volume":"40","author":"Solans","year":"2001","journal-title":"Rheumatology (Oxford)."},{"key":"10.1016\/j.medcli.2023.01.003_bib0400","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1097\/00005792-199601000-00003","article-title":"Prognostic factors in polyarteritis nodosa and Churg-Strauss syndrome. A prospective study in 342 patients","volume":"75","author":"Guillevin","year":"1996","journal-title":"Medicine (Baltimore)."},{"key":"10.1016\/j.medcli.2023.01.003_bib0405","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/S0140-6736(03)12518-4","article-title":"Churg-Strauss syndrome","volume":"361","author":"Noth","year":"2003","journal-title":"Lancet."},{"key":"10.1016\/j.medcli.2023.01.003_bib0410","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1097\/00005792-199901000-00003","article-title":"Churg-Strauss syndrome: Clinical study and long-term follow-up of 96 patients","volume":"78","author":"Guillevin","year":"1999","journal-title":"Medicine (Baltimore)."},{"key":"10.1016\/j.medcli.2023.01.003_bib0415","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1159\/000442040","article-title":"Otologic and Rhinologic Manifestations of Eosinophilic Granulomatosis with Polyangiitis","volume":"21","author":"Nakamaru","year":"2016","journal-title":"Audiol Neurootol."},{"key":"10.1016\/j.medcli.2023.01.003_bib0420","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1097\/MD.0b013e318205a4c6","article-title":"The five-factor score revisited: Assessment of prognoses of systemic necrotizing vasculitides based on the French Vasculitis Study Group (FVSG) cohort","volume":"90","author":"Guillevin","year":"2011","journal-title":"Medicine (Baltimore)."},{"key":"10.1016\/j.medcli.2023.01.003_bib0425","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.berh.2009.02.004","article-title":"Churg-Strauss angiitis","volume":"23","author":"Sinico","year":"2009","journal-title":"Best Pract Res Clin Rheumatol."},{"key":"10.1016\/j.medcli.2023.01.003_bib0430","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1097\/01.md.0000180793.80212.17","article-title":"Deaths occurring during the first year after treatment onset for polyarteritis nodosa, microscopic polyangiitis, and Churg-Strauss syndrome: A retrospective analysis of causes and factors predictive of mortality based on 595 patients","volume":"84","author":"Bourgarit","year":"2005","journal-title":"Medicine (Baltimore)."},{"issue":"Suppl. 129","key":"10.1016\/j.medcli.2023.01.003_bib0435","doi-asserted-by":"crossref","first-page":"3","DOI":"10.55563\/clinexprheumatol\/v1tpfo","article-title":"One year in review 2021: Systemic vasculitis","volume":"39","author":"Ferro","year":"2021","journal-title":"Clin Exp Rheumatol."},{"key":"10.1016\/j.medcli.2023.01.003_bib0440","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1136\/bmj.320.7245.1325","article-title":"ABC of arterial and vascular disease: Vasculitis","volume":"320","author":"Savage","year":"2000","journal-title":"BMJ."},{"key":"10.1016\/j.medcli.2023.01.003_bib0445","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1093\/rheumatology\/keu427","article-title":"Value of commonly measured laboratory tests as biomarkers of disease activity and predictors of relapse in eosinophilic granulomatosis with polyangiitis","volume":"54","author":"Grayson","year":"2015","journal-title":"Rheumatol (Oxford)."},{"key":"10.1016\/j.medcli.2023.01.003_bib0450","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1007\/s40265-018-0920-8","article-title":"Treatment of Eosinophilic Granulomatosis with Polyangiitis: A Review","volume":"78","author":"Raffray","year":"2018","journal-title":"Drugs."},{"key":"10.1016\/j.medcli.2023.01.003_bib0455","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1111\/j.1398-9995.2007.01486.x","article-title":"The common allergens in the Churg-Strauss syndrome","volume":"62","author":"Bottero","year":"2007","journal-title":"Allergy."},{"key":"10.1016\/j.medcli.2023.01.003_bib0460","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1136\/ard.2011.155382","article-title":"IgG4 immune response in Churg-Strauss syndrome","volume":"71","author":"Vaglio","year":"2012","journal-title":"Ann Rheum Dis."},{"key":"10.1016\/j.medcli.2023.01.003_bib0465","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/j.ejim.2015.04.022","article-title":"Eosinophilic granulomatosis with polyangiitis (Churg-Strauss) (EGPA) Consensus Task Force recommendations for evaluation and management","volume":"26","author":"Groh","year":"2015","journal-title":"Eur J Intern Med."},{"key":"10.1016\/j.medcli.2023.01.003_bib0470","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1136\/annrheumdis-2021-221794","article-title":"2022 American College of Rheumatology\/European Alliance of Associations for Rheumatology Classification Criteria for Eosinophilic Granulomatosis with Polyangiitis","volume":"81","author":"Grayson","year":"2022","journal-title":"Ann Rheum Dis."},{"issue":"2 Suppl. 41","key":"10.1016\/j.medcli.2023.01.003_bib0475","first-page":"S48","article-title":"Respiratory system involvement in systemic vasculitides","volume":"24","author":"Manganelli","year":"2006","journal-title":"Clin Exp Rheumatol."},{"key":"10.1016\/j.medcli.2023.01.003_bib0480","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1002\/acr2.11230","article-title":"Granulomatosis With Polyangiitis and Microscopic Polyangiitis: A Systematic Review and Meta-Analysis of Benefits and Harms of Common Treatments","volume":"3","author":"Springer","year":"2021","journal-title":"ACR Open Rheumatol."},{"key":"10.1016\/j.medcli.2023.01.003_bib0485","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1038\/modpathol.3880475","article-title":"Recent advances in the diagnosis of Churg-Strauss syndrome","volume":"14","author":"Churg","year":"2001","journal-title":"Mod Pathol."},{"key":"10.1016\/j.medcli.2023.01.003_bib0490","doi-asserted-by":"crossref","first-page":"2589","DOI":"10.1002\/art.21253","article-title":"Churg-Strauss syndrome: Just one disease entity?","volume":"52","author":"Kallenberg","year":"2005","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.medcli.2023.01.003_bib0495","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1097\/BOR.0b013e328333390b","article-title":"Churg-Strauss syndrome: Evidence for disease subtypes?","volume":"22","author":"Pagnoux","year":"2010","journal-title":"Curr Opin Rheumatol."},{"key":"10.1016\/j.medcli.2023.01.003_bib0500","first-page":"20","article-title":"Genetically distinct clinical subsets, and associations with asthma and eosinophil abundance, within Eosinophilic Granulomatosis with Polyangiitis","volume":"26","author":"Lyons","year":"2018","journal-title":"bioRxiv"},{"key":"10.1016\/j.medcli.2023.01.003_bib0505","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1002\/art.41984","article-title":"New Classification Criteria for Small-Vessel Vasculitis: Is Antineutrophil Cytoplasmic Antibody Inclusion Their Major Advance?","volume":"74","author":"Dejaco","year":"2022","journal-title":"Arthritis Rheumatol."},{"key":"10.1016\/j.medcli.2023.01.003_bib0510","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1002\/ajh.24880","article-title":"World Health Organization-defined eosinophilic disorders: 2017 update on diagnosis, risk stratification, and management","volume":"92","author":"Gotlib","year":"2017","journal-title":"Am J Hematol."},{"key":"10.1016\/j.medcli.2023.01.003_bib0515","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1136\/annrheumdis-2016-209133","article-title":"EULAR\/ERA-EDTA recommendations for the management of ANCA-associated vasculitis","volume":"75","author":"Yates","year":"2016","journal-title":"Ann Rheum Dis."},{"key":"10.1016\/j.medcli.2023.01.003_bib0520","doi-asserted-by":"crossref","first-page":"105285","DOI":"10.1016\/j.jbspin.2021.105285","article-title":"How to taper glucocorticoids in inflammatory rheumatic diseases? A narrative review of novel evidence in rheumatoid arthritis, systemic lupus erythematosus, and giant cell arteritis","volume":"89","author":"Buttgereit","year":"2022","journal-title":"Joint Bone Spine."},{"key":"10.1016\/j.medcli.2023.01.003_bib0525","doi-asserted-by":"crossref","first-page":"2187","DOI":"10.1002\/art.1780401213","article-title":"A prospective, multicenter, randomized trial comparing steroids and pulse cyclophosphamide versus steroids and oral cyclophosphamide in the treatment of generalized Wegener's granulomatosis","volume":"40","author":"Guillevin","year":"1997","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.medcli.2023.01.003_bib0530","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1002\/acr2.11194","article-title":"Eosinophilic Granulomatosis with Polyangiitis: A Systematic Review and Meta-Analysis of Test Accuracy and Benefits and Harms of Common Treatments","volume":"3","author":"Springer","year":"2021","journal-title":"ACR Open Rheumatol."},{"key":"10.1016\/j.medcli.2023.01.003_bib0535","doi-asserted-by":"crossref","first-page":"102737","DOI":"10.1016\/j.autrev.2020.102737","article-title":"Rituximab for the treatment of eosinophilic granulomatosis with polyangiitis: A systematic literature review","volume":"20","author":"Akiyama","year":"2021","journal-title":"Autoimmun Rev."},{"key":"10.1016\/j.medcli.2023.01.003_bib0540","doi-asserted-by":"crossref","first-page":"1921","DOI":"10.1056\/NEJMoa1702079","article-title":"Mepolizumab or Placebo for Eosinophilic Granulomatosis with Polyangiitis","volume":"376","author":"Wechsler","year":"2017","journal-title":"N Engl J Med."},{"key":"10.1016\/j.medcli.2023.01.003_bib0545","doi-asserted-by":"crossref","first-page":"2170","DOI":"10.1016\/j.jaci.2018.11.041","article-title":"Evaluation of clinical benefit from treatment with mepolizumab for patients with eosinophilic granulomatosis with polyangiitis","volume":"143","author":"Steinfeld","year":"2019","journal-title":"J Allergy Clin Immunol."},{"key":"10.1016\/j.medcli.2023.01.003_bib0550","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1002\/art.41943","article-title":"Mepolizumab for Eosinophilic Granulomatosis With Polyangiitis: A European Multicenter Observational Study","volume":"74","author":"Bettiol","year":"2022","journal-title":"Arthritis Rheumatol."},{"key":"10.1016\/j.medcli.2023.01.003_bib0555","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1016\/j.anai.2021.01.035","article-title":"Efficacy and safety of reslizumab in the treatment of eosinophilic granulomatosis with polyangiitis","volume":"126","author":"Manka","year":"2021","journal-title":"Ann Allergy Asthma Immunol."},{"key":"10.1016\/j.medcli.2023.01.003_bib0560","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fphar.2022.865318","article-title":"Perspectives on the Efficacy of Benralizumab for Treatment of Eosinophilic Granulomatosis With Polyangiitis","volume":"13","author":"Koga","year":"2022","journal-title":"Front Pharmacol."},{"key":"10.1016\/j.medcli.2023.01.003_bib0565","doi-asserted-by":"crossref","first-page":"2274","DOI":"10.1002\/art.39663","article-title":"Anti-IgE Monoclonal Antibody (Omalizumab) in Refractory and Relapsing Eosinophilic Granulomatosis With Polyangiitis (Churg-Strauss): Data on Seventeen Patients","volume":"68","author":"Jachiet","year":"2016","journal-title":"Arthritis Rheumatol."},{"key":"10.1016\/j.medcli.2023.01.003_bib0570","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/s40413-018-0217-0","article-title":"Omalizumab in the treatment of eosinophilic granulomatosis with polyangiitis (EGPA): Single-centerexperience in 18 cases","volume":"11","author":"Celebi Sozener","year":"2018","journal-title":"World Allergy Organ J."},{"key":"10.1016\/j.medcli.2023.01.003_bib0575","doi-asserted-by":"crossref","first-page":"217","DOI":"10.2177\/jsci.36.217","article-title":"Efficacy of high- dose intravenous immunoglobulin therapy for peripheral neuropathy in the remission stage of eosinophilic granulomatosis with polyangiitis (EGPA Churg-Strauss syndrome)","volume":"36","author":"Matsuda","year":"2013","journal-title":"Nihon Rinsho Meneki Gakkai Kaishi."},{"key":"10.1016\/j.medcli.2023.01.003_bib0580","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1186\/1752-1947-6-310","article-title":"Effective intravenous immunoglobulin therapy for Churg-Strauss syndrome (allergic granulomatous angiitis) complicated by neuropathy of the eighth cranial nerve: A case report","volume":"6","author":"Ozaki","year":"2012","journal-title":"J Med Case Rep."},{"key":"10.1016\/j.medcli.2023.01.003_bib0585","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1097\/BOR.0b013e32834120c1","article-title":"Plasma exchange in the treatment of Wegener's granulomatosis, microscopic polyangiitis, Churg-Strauss syndrome and renal limited vasculitis","volume":"23","author":"Casian","year":"2011","journal-title":"Curr Opin Rheumatol."},{"key":"10.1016\/j.medcli.2023.01.003_bib0590","first-page":"24","article-title":"Interferon-alpha for maintenance of remission in Churg-Strauss syndrome: a long-term observational study","volume":"28","author":"Metzler","year":"2010","journal-title":"Clin Exp Rheumatol."},{"key":"10.1016\/j.medcli.2023.01.003_bib0595","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1136\/annrheumdis-2022-eular.3156","article-title":"POS0830 Systematic literature review informing the 2022 update of the EULAR recommendations for the management of ANCA-associated vasculitis: focus on treatment strategies","volume":"81","author":"Schirmer","year":"2022","journal-title":"Ann Rheum Dis."},{"key":"10.1016\/j.medcli.2023.01.003_bib0600","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1002\/acr2.11263","article-title":"Clinical Manifestations and Long-Term Outcomes of Eosinophilic Granulomatosis With Polyangiitis in North America","volume":"3","author":"Doubelt","year":"2021","journal-title":"ACR Open Rheumatol."}],"container-title":["Medicina Cl\u00ednica"],"original-title":[],"language":"es","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002577532300012X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002577532300012X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,21]],"date-time":"2025-09-21T01:55:58Z","timestamp":1758419758000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S002577532300012X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4]]},"references-count":60,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2023,4]]}},"alternative-id":["S002577532300012X"],"URL":"https:\/\/doi.org\/10.1016\/j.medcli.2023.01.003","relation":{},"ISSN":["0025-7753"],"issn-type":[{"value":"0025-7753","type":"print"}],"subject":[],"published":{"date-parts":[[2023,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Granulomatosis eosinof\u00edlica con poliange\u00edtis","name":"articletitle","label":"Article Title"},{"value":"Medicina Cl\u00ednica","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.medcli.2023.01.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Espa\u00f1a, S.L.U. All rights reserved.","name":"copyright","label":"Copyright"}]}}